Cenova’s business covers the complete value chain related to plastic component manufacturing and final product assembly. The majority of the business is towards the medical device industry but also covers the food processing industry.
Both areas have requirements of an ISO-classified clean room environment for their production.
The people establishing Cenova back in 1972 were innovators well connected with the medical industry. In 1984, they started to manufacture prototypes for companies like Astra. During the years that followed, the customers requested production of greater series and Cenova increased their production volume as a result.
In 1998, Cenova started production in cleanroom environments in new facilities close to the E4 highway, north of Mjölby.
”In general, the company has had a steady growth all the time, but from the year 2000 and onwards it has really taken-off and the turnover has increased from MSEK 15 to MSEK 60-70. The company currently employs 56 full-time and an additional 12-15 people through fixed terms and employment agencies,” says Sören Wilhelmsson, Managing Director of Cenova AB.
Cenova’s business is based on developing and producing plastic components for equipment with high regulatory demands, such as medical equipment or instruments used in the food industry. Their services include injection moulding, thermoforming and
clean room assembly. Those basic services combine to an extensive variation of final applications and logistics solutions.
”We, for example, mould plastic parts to a spray nozzle and assemble them in a fully automated process to complete products. The services also include sterilisation and global distribution.”
Other examples, named by Sören Wilhelmsson, are aseptic sample units, plastic details for hearing implant, DNA-testing components and tubes with cannulas for flavouring dairy products.
Rationalisation and increased efficiency
Cenova is currently experiencing a high demand for the products they produce which increases the demand on production efficiency programs.
”We’ve had a good annual growth and aim at reaching a turnover of MSEK 100 within a couple of years. We of course want to grow with our existing customers, but also to find new ones. The food industry is a segment closely related to the medical industry, regulatory wise, and a segment in which we ought to be able to grow. Veterinary products is another area where we hope to make progress within a year or two,” says Sören Wilhelmsson.
The current capacity, in terms of machinery equipment and space in the production facilities, is more than enough for the company to reach a turnover of MSEK 100. However, Cenova is currently adapting the facilities to create a better flow in the production process. They call it the Cenova Lean Manufacturing process or Clean Manufacturing for short.
”We’re constantly working with increasing our efficiency and we are right now planning our next robotic cell combining injection moulding and assembly. We have gone from three shifts, two years ago, to one day-shift and a somewhat smaller second shift keeping up the same capacity,” says Sören Wilhelmsson.
Since 1994, Cenova is part of the Gepe Group, which also includes Sterisol AB in Vadstena and GEPE-Geimuplast in Germany, among other companies. The group is headquartered in Switzerland.